Richard Graydon
Hoofd Techniek/Wetenschap/O&O bij ATOSSA THERAPEUTICS, INC.
Profiel
Dr. Richard Graydon is a Chief Medical Officer at Atossa Therapeutics, Inc. Dr. Graydon was previously employed as a Director-Clinical Development by Daiichi Sankyo, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Stanford University.
Actieve functies van Richard Graydon
| Bedrijven | Functie | Begin |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 25-10-2022 |
Eerdere bekende functies van Richard Graydon
| Bedrijven | Functie | Einde |
|---|---|---|
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Richard Graydon
| Stanford University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |